Praxis Investment Management Inc. Takes Position in Marsh & McLennan Companies, Inc. $MRSH

Praxis Investment Management Inc. bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,432 shares of the financial services provider’s stock, valued at approximately $2,330,000.

Several other institutional investors also recently modified their holdings of MRSH. Procyon Advisors LLC raised its position in shares of Marsh & McLennan Companies by 2.5% during the fourth quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider’s stock worth $423,000 after purchasing an additional 56 shares during the period. PFG Investments LLC raised its holdings in Marsh & McLennan Companies by 3.3% during the 4th quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider’s stock worth $326,000 after buying an additional 56 shares during the period. Lindenwold Advisors INC lifted its stake in Marsh & McLennan Companies by 0.4% during the third quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider’s stock valued at $3,022,000 after buying an additional 62 shares in the last quarter. SeaCrest Wealth Management LLC boosted its holdings in shares of Marsh & McLennan Companies by 3.9% in the fourth quarter. SeaCrest Wealth Management LLC now owns 1,673 shares of the financial services provider’s stock worth $306,000 after buying an additional 63 shares during the period. Finally, EP Wealth Advisors LLC increased its position in shares of Marsh & McLennan Companies by 0.8% in the second quarter. EP Wealth Advisors LLC now owns 8,337 shares of the financial services provider’s stock worth $1,823,000 after acquiring an additional 69 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of NYSE MRSH opened at $178.13 on Friday. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $216.32. The company has a market capitalization of $86.05 billion, a P/E ratio of 22.27, a PEG ratio of 2.60 and a beta of 0.61. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last issued its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm’s revenue was up 7.6% compared to the same quarter last year. Equities analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

MRSH has been the subject of several research analyst reports. Wells Fargo & Company reduced their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research report on Thursday, April 9th. Morgan Stanley decreased their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a report on Monday, April 6th. Citigroup upgraded shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a research note on Wednesday, May 6th. Barclays cut their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Finally, Piper Sandler lowered their price target on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $200.19.

View Our Latest Stock Report on MRSH

Insider Activity

In related news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Profile

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Articles

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.